News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,861 Results
Type
Article (14570)
Company Profile (102)
Press Release (285189)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (97422)
Career Advice (472)
Deals (17441)
Drug Delivery (67)
Drug Development (39929)
Employer Resources (49)
FDA (7083)
Job Trends (6563)
News (166237)
Policy (15491)
Tag
Academia (502)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (26671)
ALS (42)
Alzheimer's disease (457)
Antibody-drug conjugate (ADC) (48)
Approvals (7131)
Artificial intelligence (119)
Autoimmune disease (9)
Automation (4)
Bankruptcy (151)
Best Places to Work (4668)
BIOSECURE Act (9)
Biosimilars (62)
Biotechnology (42)
Bladder cancer (28)
Brain cancer (18)
Breast cancer (97)
Cancer (764)
Cardiovascular disease (75)
Career advice (416)
Career pathing (12)
CAR-T (26)
Cell therapy (109)
Cervical cancer (4)
Clinical research (33701)
Collaboration (392)
Compensation (158)
Complete response letters (17)
COVID-19 (865)
CRISPR (22)
C-suite (132)
Cystic fibrosis (41)
Data (766)
Denatured (15)
Depression (11)
Diabetes (92)
Diagnostics (1793)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (64)
Drug pricing (67)
Drug shortages (12)
Duchenne muscular dystrophy (47)
Earnings (35857)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (41538)
Executive appointments (417)
FDA (7595)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (248)
Gene editing (42)
Generative AI (9)
Gene therapy (115)
GLP-1 (364)
Government (1427)
Grass and pollen (4)
Guidances (21)
Healthcare (4186)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (35)
Indications (16)
Infectious disease (904)
Inflammatory bowel disease (62)
Inflation Reduction Act (7)
Influenza (18)
Intellectual property (53)
Interviews (59)
IPO (6752)
IRA (29)
Job creations (2131)
Job search strategy (380)
Kidney cancer (6)
Labor market (12)
Layoffs (183)
Leadership (4)
Legal (3784)
Liver cancer (30)
Lung cancer (105)
Lymphoma (64)
Machine learning (2)
Management (16)
Manufacturing (180)
MASH (36)
Medical device (2247)
Medtech (2250)
Mergers & acquisitions (10944)
Metabolic disorders (287)
Multiple sclerosis (27)
NASH (14)
Neurodegenerative disease (29)
Neuropsychiatric disorders (8)
Neuroscience (670)
NextGen: Class of 2025 (1697)
Non-profit (633)
Now hiring (8)
Obesity (161)
Opinion (120)
Ovarian cancer (22)
Pain (54)
Pancreatic cancer (22)
Parkinson's disease (52)
Partnered (7)
Patents (125)
Patient recruitment (36)
Peanut (10)
People (30876)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8945)
Phase II (14360)
Phase III (12575)
Pipeline (523)
Policy (73)
Postmarket research (1447)
Preclinical (3591)
Press Release (27)
Prostate cancer (53)
Psychedelics (8)
Radiopharmaceuticals (132)
Rare diseases (179)
Real estate (2908)
Recruiting (17)
Regulatory (11194)
Reports (16)
Research institute (603)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (40)
Series A (43)
Series B (17)
Service/supplier (4)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (79)
Sponsored (6)
Startups (1848)
State (2)
Stomach cancer (4)
Supply chain (33)
Tariffs (31)
The Weekly (30)
Vaccines (173)
Venture capitalists (14)
Weight loss (100)
Women's health (9)
Worklife (4)
Date
Today (71)
Last 7 days (304)
Last 30 days (1015)
Last 365 days (13133)
2025 (4327)
2024 (14063)
2023 (16100)
2022 (22799)
2021 (23374)
2020 (21937)
2019 (16682)
2018 (13050)
2017 (15468)
2016 (14651)
2015 (17260)
2014 (13929)
2013 (11943)
2012 (12847)
2011 (13344)
2010 (12125)
Location
Africa (338)
Alabama (14)
Alaska (1)
Arizona (57)
Arkansas (3)
Asia (30968)
Australia (4010)
California (1965)
Canada (1026)
China (320)
Colorado (72)
Connecticut (78)
Delaware (62)
Europe (45714)
Florida (344)
Georgia (41)
Idaho (9)
Illinois (209)
India (19)
Indiana (136)
Iowa (1)
Japan (131)
Kansas (62)
Kentucky (12)
Louisiana (2)
Maine (5)
Maryland (321)
Massachusetts (1654)
Michigan (32)
Minnesota (118)
Missouri (26)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (871)
New Mexico (7)
New York (619)
North Carolina (432)
North Dakota (2)
Northern California (795)
Ohio (51)
Oklahoma (4)
Oregon (17)
Pennsylvania (489)
Puerto Rico (8)
Rhode Island (10)
South America (553)
South Carolina (2)
Southern California (840)
Tennessee (34)
Texas (255)
United States (8130)
Utah (46)
Virginia (77)
Washington D.C. (31)
Washington State (135)
Wisconsin (18)
299,861 Results for "salix pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting data from its Phase 2 trial evaluating Amiselimod as treatment for active ulcerative colitis (UC).
May 17, 2024
·
4 min read
Business
Salix Pharmaceuticals Partners with Bellamy Young
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced its partnership with award-winning actor Bellamy Young, who is speaking out to help educate people who are impacted by hepatic encephalopathy (HE), caused by cirrhosis.
October 4, 2023
·
5 min read
Press Releases
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
March 21, 2025
·
7 min read
Business
Salix Announces 2024 Gastrointestinal Health Scholars Program
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the opening of the 2024 Salix Gastrointestinal Health Scholars Program application period.
February 12, 2024
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Business
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
Bausch Health Companies Inc. (NYSE/TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced the winners of its 2023 Salix Gastrointestinal Health Scholars Program.
July 11, 2023
·
4 min read
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Salix Pharmaceuticals today released the Salix Liver Health Trends Report, Third Edition, which documents the evolving crisis of chronic liver disease (CLD), showing a 9% increase in CLD and cirrhosis mortality marking these as the ninth leading cause of death in the United States in 2021.
October 10, 2023
·
5 min read
Business
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Bausch Health Companies Inc. today announced award-winning actor, Bellamy Young, as the brand ambassador in a new campaign to raise awareness of Xifaxan, the first and only FDA approved medication to reduce the risk of overt hepatic encephalopathy (OHE) recurrence in adults.
May 9, 2024
·
6 min read
1 of 29,987
Next
